Analysis of the Genomic Response of Human Prostate Cancer Cells to Histone Deacetylase Inhibitors

Epigenetics - United States
doi 10.4161/epi.25574
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells

Cancers
Cancer ResearchOncology
2019English

Selectively Targeting Prostate Cancer With Antiandrogen Equipped Histone Deacetylase Inhibitors

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2013English

Histone Deacetylase Inhibitors Stimulate Dedifferentiation of Human Breast Cancer Cells Through WNT/β-Catenin Signaling

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2012English

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Inhibitors of Histone-Deacetylase

Journal of Applied Biomedicine
GeneticsMolecular BiologyPharmacologyBiochemistryBiological SciencesToxicologyMedicineAgriculturalNeurosciencePharmaceutics
2005English

Thioredoxin in Cancer—Role of Histone Deacetylase Inhibitors

Seminars in Cancer Biology
Cancer Research
2006English

Anti-Estrogenic Actions of Histone Deacetylase Inhibitors in McF-7 Breast Cancer Cells

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2007English

Histone Deacetylase Inhibitors Specifically Kill Nonproliferating Tumour Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy